Trefethen Advisors' broad-based financial and strategic advisory experience extends across a range of situations, industries and transaction sizes. The firm's professionals have executed the following selected transactions, among others:
The bankers of Trefethen Advisors acted as financial advisor to ATS on its Chapter 11 financial restructuring
The bankers of Trefethen Advisors acted as financial advisor to Shield Healthcare management on and assisted in raising financing for buyout of controlling interest from Kobayashi Pharmaceuticals Co., Ltd.
The bankers of Trefethen Advisors acted as financial advisor on the sale of this 252-bed nursing home in Missouri
The bankers of Trefethen Advisors acted as financial advisor to Dornoch Medical on the sale to Zimmer Surgical
The bankers of Trefethen Advisors acted as financial advisor to The Fountains senior bank group in an out-of-court restructuring
The bankers of Trefethen Advisors acted as financial advisor to KPC and placed the financing to facilitate a transaction
The bankers of Trefethen Advisors provided expert testimony during litigation
The bankers of Trefethen Advisors acted as financial advisor to NHHC on its acquisition program
The bankers of Trefethen Advisors acted as financial advisor to CNS Network and placed the financing to facilitate a transaction
The bankers of Trefethen Advisors provided expert damages testimony in support of patent infringement litigation against Baylor Healthcare
The bankers of Trefethen Advisors provided expert testimony during litigation to assist in defending claims concerning Genentech's treatment for vision loss
The bankers of Trefethen Advisors provided expert valuation testimony in support of insurance recovery claim during litigation
The bankers of Trefethen Advisors acted as financial advisor to Meyer Pharmaceutical
The bankers of Trefethen Advisors acted as financial advisor to on the sale of ATS' human collagen royalty rights to Black Horse Capital
The bankers of Trefethen Advisors acted as financial advisor on the sale of ATS' cardiovascular royalty and milestone rights
The bankers of Trefethen Advisors acted as financial advisor on the sale of ATS' Segenix royalty and milestone rights to RegeneMed, Inc.
The bankers of Trefethen Advisors acted as financial advisor on the sale of ATS' cardiovascular intellectual property rights
The bankers of Trefethen Advisors acted as financial advisor on the sale of ATS' Segenix intellectual property rights to RegeneMed, Inc.
The bankers of Trefethen Advisors acted as financial advisor on the sale of the ATS' Nouricel product line to SkinMedica
The bankers of Trefethen Advisors acted as financial advisor on the sale of ATS' intellectual property rights to Smith & Nephew Wound Healing
The bankers of Trefethen Advisors acted as financial advisor to Cornova on their equity raise
The bankers of Trefethen Advisors acted as financial advisor to Eyecare Service Plan on the sale to Spectera, Inc.
The bankers of Trefethen Advisors acted as financial advisor to Newcardio on their equity raise
Finetune is unique in its ability to provide a spectrum of financing options to large and mid sized artists, labels, and publishers. Whether you're looking to sell, or to finance a new venture, we can help.
Contact Us
